Back

Conserved principles of spatial biology define tumor heterogeneity and response to immunotherapy

Behera, V.; Giba, H.; Pen, U.-Y.; Di Lello, A.; Doran, B. A.; Esposito, A.; Pezeshk, A.; Bestvina, C.; Kline, J.; Garassino, M.; Raman, A.

2024-10-22 cancer biology
10.1101/2024.10.18.619136 bioRxiv
Show abstract

The complexity of tumor microenvironments (TMEs) poses a substantial challenge to understanding tumor heterogeneity and clinical outcomes. By studying an ensemble of 262 diverse solid tumors, we uncovered a conserved, hierarchical architecture of transcriptionally covarying regions we term Spatial Groups (SGs). SGs corresponded to discrete biological units as benchmarked against multiple spatial technologies, and their nested organization revealed context-dependent constraints within tumors. Using SGs for comparing tumors, we derived a pantumor classification where immune spatial heterogeneity was the dominant axis of variation. This classification stratified response to immune checkpoint blockade in an out-of-sample cohort of non-small cell lung cancer patients. Statistical approximation techniques defined a sparse set of protein markers capturing system-level properties of TME spatial biology, demonstrating a framework for distilling genome-wide information into clinically deployable diagnostics. Our findings position the architecture of SGs as a general model unifying TME structure with biological function and clinical translation.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.